4-Year Follow-Up After Transcatheter Tricuspid Valve Replacement Using the EVOQUE System
oleh: Lukas Stolz, MD, Thomas J. Stocker, MD, Ludwig T. Weckbach, MD, Simon Schmid, Cand med, Julia Novotny, MD, Philipp M. Doldi, MD, Steffen Massberg, MD, Michael Näbauer, MD, Jörg Hausleiter, MD
| Format: | Article |
|---|---|
| Diterbitkan: | Elsevier 2024-07-01 |
Deskripsi
Transcatheter tricuspid valve replacement (TTVR) is an increasingly used treatment technique for patients with severe tricuspid regurgitation (TR). Currently, available data from international registries and randomized controlled trials provide outcome data until a maximum follow-up of 2 years after the procedure. This case report presents 4-year follow-up data for an 84-year-old woman who underwent TTVR for torrential TR in 2019. The patient experienced durable TR reduction, symptomatic improvement, right ventricular reverse remodeling, and substantial improvement in liver and kidney function.